Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NEUROZYM BIOTECH AS
AS
Active
Org 961251273
Murbræk, 7760 Snåsa
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 1991
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+26% vs 2023
Equity ratio
12.6%
Financial strength
Net profit 2024
NOK 984K
+1492% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -91K
+26%
Net profit
NOK 984K
+1492%
Total assets
NOK 4,7M
+25%
Equity
NOK 594K
+252%
Employees
1
—
Company information
Legal name
NEUROZYM BIOTECH AS
Org number
961251273
Legal form
Aksjeselskap
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
3. juli 1991
Share capital
NOK 230 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Contact
Address
Murbræk, 7760 Snåsa
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Snåsa
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
575
584
360
0
0
Staff expenses
−67
−171
−178
−14
−0
EBITDA
70
135
−75
−124
−91
Depreciation & amort.
−37
−26
−4
−4
−4
EBIT
33
109
−79
−127
−95
Net financials
0
4
21
56
58
Profit before tax
33
113
−58
−71
−36
Tax
−0
−0
−0
−0
−1 020
Net profit
33
113
−58
−71
984
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
3 678
3 879
3 905
3 779
4 729
Equity
−374
−261
−320
−390
594
Long-term debt
4 007
4 026
4 158
4 135
4 102
Short-term debt
46
114
67
35
34
Total debt
4 053
4 140
4 225
4 169
4 136
Financial ratios
5-year trend
EBITDA margin
-9123600.0%
This company
15.8%
Market median
-57744404% vs market
2020
2024
Equity ratio
12.6%
This company
38.2%
Market median
-67% vs market
2020
2024
Return on equity
165.7%
This company
18.4%
Market median
+801% vs market
2020
2024
Net profit margin
98375900.0%
This company
8.1%
Market median
+1214517184% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
6.97×
This company
0.62×
Market median
-1024% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
GO
Gunnar Otto Brønstad
Board of Directors
2020
AB
Aase Brønstad
Board of Directors
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Håkon Brønstad
Individual
12%
12%
2024
Eivind Brønstad
Individual
12%
12%
2024
Maria Brønstad
Individual
12%
12%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
NEUROZYM BIOTECH AS
(this company)
ZYMBIO AS
Board network connections
Board members of NEUROZYM BIOTECH AS also hold positions in
0
other companies.
Person
Role here
Other companies
Gunnar Otto Brønstad
Board of Directors
0 companies
Aase Brønstad
Board of Directors
0 companies